Sansure Biotech Inc. was founded in 2008 as a dedicated company developing and manufacturing a complete product line for molecular laboratories, ranging from upstream nucleic acid extraction kits and full automation to downstream real time PCR diagnostic & research kits and fluorescence systems.
Based on innovative R&D center in Changsha, China, Sansure understands its capability and social responsibility to offer molecular diagnostic products consistent in quality, accurate and reliable in test results, easy to use and accessible to laboratories of all levels despite their variety in lab environment. Sansure is gradually winning its reputation all over the world and exerting growing influence on popularizing qPCR technologies towards what they are supposed to be as affordable and accessible human health care means.
Sansure started domestic sales in 2010, and by the end of 2016 had ranked No.2 in terms of market share in China with more than 1000 hospitals and laboratories contributing to daily consumption of over 50,000 tests. In 2016, eight out of the ten top hospitals specialized in infectious diseases are Sansure loyal clients. Globally, Sansure innovative technologies now have been introduced into more than 30 countries and regions including Europe, Middle East, Asia, Africa and South and Central America where Sansure has received recognition since 2014.